Prediagnostic body mass index and pancreatic cancer survival.
about
Oncogenic role of leptin and Notch interleukin-1 leptin crosstalk outcome in cancerPancreatic Cancer Metabolism: Breaking It Down to Build It Back UpTargeting p110gamma in gastrointestinal cancers: attack on multiple frontsObesity and cancer pathogenesis.Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to Chemotherapy.Leptin-Notch signaling axis is involved in pancreatic cancer progressionDietary energy balance modulates ovarian cancer progression and metastasis.Survival in overweight patients with advanced pancreatic carcinoma: a multicentre cohort study.Obesity and head and neck cancer risk and survival by human papillomavirus serology.Metformin prevents aggressive ovarian cancer growth driven by high-energy diet: similarity with calorie restriction.Severe obesity prior to diagnosis limits survival in colorectal cancer patients evaluated at a large cancer centreInfluence of Body Mass Index and Albumin on Perioperative Morbidity and Clinical Outcomes in Resected Pancreatic Adenocarcinoma.Effect of Body Mass Index on Overall Survival of Pancreatic Cancer: A Meta-AnalysisAn Attempt to Evaluate Selected Aspects of "Bone-Fat Axis" Function in Healthy Individuals and Patients With Pancreatic CancerImpacts of new-onset and long-term diabetes on clinical outcome of pancreatic cancer.Evaluation of Body Mass Index and Survival of Nasopharyngeal Carcinoma by Propensity-Matched Analysis: An Observational Case-Control Study.Circulating Metabolites and Survival Among Patients With Pancreatic CancerPremorbid Obesity and Mortality in Patients With Pancreatic Cancer: A Systematic Review and Meta-analysis.Prediagnostic Plasma 25-Hydroxyvitamin D and Pancreatic Cancer SurvivalA pilot study of radiologic measures of abdominal adiposity: weighty contributors to early pancreatic carcinogenesis worth evaluating?TTD consensus document on the diagnosis and management of exocrine pancreatic cancer.Prognostic factors related with survival in patients with pancreatic adenocarcinomaPredicting early mortality in resectable pancreatic adenocarcinoma: A cohort study.Cigarette Smoking and Pancreatic Cancer Survival.Critical role for arginase 2 in obesity-associated pancreatic cancer.A high BMI is a risk factor in younger patients with de novo acute myelogenous leukemia.Positive Effect of Higher Adult Body Mass Index on Overall Survival of Digestive System Cancers Except Pancreatic Cancer: A Systematic Review and Meta-Analysis.Body mass index does not affect the survival of pancreatic cancer patients.Use of Angiotensin System Inhibitors Is Associated with Immune Activation and Longer Survival in Nonmetastatic Pancreatic Ductal Adenocarcinoma.Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling.Obesity and Pancreatic Cancer.Inflammatory, insulin resistance metabolic markers and pancreatic cancer: quo vadis? [corrected].Plasma inflammatory cytokines and survival of pancreatic cancer patients.The Plausibility of Obesity Paradox in Cancer-Point.Visceral and subcutaneous fat as new independent predictive factors of survival in locally advanced gastric carcinoma patients treated with neo-adjuvant chemotherapy.Impact of sarcopenia in borderline resectable and locally advanced pancreatic cancer patients receiving stereotactic body radiation therapy.Cachexia, and not obesity, prior to pancreatic cancer diagnosis worsens survival and is negated by chemotherapy.Altered exocrine function can drive adipose wasting in early pancreatic cancer
P2860
Q26750563-2626FEC1-D6F1-4850-88B3-06FBDCC09CE7Q26780372-00286BFD-0755-435B-A4D4-EE2D3D427273Q26823575-B57645E9-453B-464C-ADA2-897A9F30F4DCQ30361298-0BD508C6-6DC8-48DC-8081-F7844D9B802CQ30388746-6A6E58C0-C395-4641-A4C6-2FD25A8511E7Q30396675-52CBAA29-2090-4A27-8A0F-B3DDECA3D45FQ34227594-B41FA962-28D2-4B0B-8145-52A43CF14BC9Q34566049-6F6038B1-B20E-448D-9E31-CB459A6D10D5Q34998853-BD05D00B-5BC1-431C-B799-96975F338774Q35793665-4DDFB992-38E5-4140-86ED-103225AFFE74Q35872088-3A5D15B9-D3C8-41B5-9C30-DAEA60E191CAQ35970523-75A78195-0836-45E5-940C-DBF7FF2F3712Q35983454-89393522-F9E6-4E83-ACF8-D1CD1C9C8A40Q36195090-88D901D2-3A02-4308-8284-0133CC0449EFQ36309449-7003E210-3BF6-481A-8C4D-FCB11D75080FQ36478060-E71B54C4-C922-4004-85CC-7B4080481B52Q36848069-23B741E9-015C-49DF-B51D-5EF7F21C864FQ37033546-584576C8-334A-4BFD-843F-3B5A0B848FCEQ37234780-5C0B26F6-17E6-4101-8212-50D80D788D05Q37720426-BFE24564-81DE-431D-A8C9-73035C6ECAAFQ38204280-BB6AAA94-61CB-4A30-B3BB-C542670B9387Q38242807-B356266F-11F2-415D-BCD9-05E0E727E75DQ39040017-A8AAD01A-9FE4-49FA-ADD7-B1ABD098438DQ40266936-3E515AD2-42B5-436A-A5BF-9385F767B7FCQ41388458-ADBE70C0-4A17-4946-9A26-60AB7EAA2126Q41479185-5E981722-39BC-4D32-91F6-CF468E661012Q41691021-A3797CAB-D47C-4501-9F30-9DEF4A4F3A23Q42183979-46C8F3C6-AFC4-4D9E-A291-13E6272BF83FQ42776799-7BDC6D5C-A5D2-4FCA-AC9B-3A016B3CC798Q48276795-F0F8E2D6-7861-4B6F-BAA5-A5DCB05426DCQ50856729-3DC49980-1F02-4B65-AA1A-105B00B0ABFAQ51217477-54623152-80B8-4402-837E-F4FE51C40D04Q52565516-32FD53C8-1818-4FC6-9A50-D9D124343FA1Q53073930-20DCB9F5-6812-4AA5-B0FA-34781464F1D3Q53225944-92FFBFFB-DCF8-419E-AC4F-ADF1105BDD74Q54965039-FD1D8BA2-A543-4ACB-ACB8-D9E96029097FQ55259105-81395EBE-AB47-466E-9E2B-D245036CFD25Q59071091-D4968239-F8FC-423B-A97A-B090ABC2C35C
P2860
Prediagnostic body mass index and pancreatic cancer survival.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Prediagnostic body mass index and pancreatic cancer survival.
@ast
Prediagnostic body mass index and pancreatic cancer survival.
@en
Prediagnostic body mass index and pancreatic cancer survival.
@nl
type
label
Prediagnostic body mass index and pancreatic cancer survival.
@ast
Prediagnostic body mass index and pancreatic cancer survival.
@en
Prediagnostic body mass index and pancreatic cancer survival.
@nl
prefLabel
Prediagnostic body mass index and pancreatic cancer survival.
@ast
Prediagnostic body mass index and pancreatic cancer survival.
@en
Prediagnostic body mass index and pancreatic cancer survival.
@nl
P2093
P2860
P50
P356
P1476
Prediagnostic body mass index and pancreatic cancer survival.
@en
P2093
Brian M Wolpin
Douglas A Rubinson
Shuji Ogino
Zhi Rong Qian
P2860
P304
P356
10.1200/JCO.2013.51.7532
P407
P577
2013-10-21T00:00:00Z